Baxter International Inc. (BAX)
NYSE: BAX · Real-Time Price · USD
32.95
-0.65 (-1.93%)
Mar 25, 2025, 4:00 PM EST - Market closed
Baxter International Market Cap
Baxter International has a market cap or net worth of $16.85 billion as of March 25, 2025. Its market cap has decreased by -24.18% in one year.
Market Cap
16.85B
Enterprise Value
28.54B
1-Year Change
-24.18%
Ranking
Category
Stock Price
$32.95
Market Cap Chart
Since December 1, 1998, Baxter International's market cap has decreased from $18.88B to $16.85B, a decrease of -10.72%. That is a compound annual growth rate of -0.43%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 25, 2025 | 16.85B | 13.19% |
Dec 31, 2024 | 14.89B | -24.09% |
Dec 29, 2023 | 19.61B | -23.67% |
Dec 30, 2022 | 25.70B | -40.22% |
Dec 31, 2021 | 42.98B | 4.86% |
Dec 31, 2020 | 40.99B | -3.99% |
Dec 31, 2019 | 42.69B | 21.89% |
Dec 31, 2018 | 35.03B | -0.55% |
Dec 29, 2017 | 35.22B | 46.03% |
Dec 30, 2016 | 24.12B | 15.57% |
Dec 31, 2015 | 20.87B | -47.46% |
Dec 31, 2014 | 39.72B | 5.24% |
Dec 31, 2013 | 37.74B | 3.07% |
Dec 31, 2012 | 36.62B | 31.26% |
Dec 30, 2011 | 27.90B | -5.42% |
Dec 31, 2010 | 29.50B | -16.62% |
Dec 31, 2009 | 35.38B | 6.44% |
Dec 31, 2008 | 33.24B | -9.71% |
Dec 31, 2007 | 36.81B | 21.24% |
Dec 29, 2006 | 30.36B | 29.31% |
Dec 30, 2005 | 23.48B | 10.27% |
Dec 31, 2004 | 21.29B | 14.31% |
Dec 31, 2003 | 18.63B | 12.13% |
Dec 31, 2002 | 16.61B | -47.53% |
Dec 31, 2001 | 31.66B | 21.88% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 766.33B |
UnitedHealth Group | 471.37B |
Johnson & Johnson | 389.31B |
AbbVie | 356.77B |
Novo Nordisk | 335.17B |
AstraZeneca | 229.25B |
Merck & Co. | 222.32B |
Novartis AG | 219.27B |